Produktneuigkeiten Hier finden Sie die neuesten Produktinformationen
-
Obtained CE-IVD marking for Allplex™ 2019-nCoV Assay
Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ 2019-nCoV Assay. This assay is a multiplex Real-time PCR assay that detects and identifies the new coronavirus named as COVID-19 using three target genes, E gene, RdRP gene and N gene. Allplex 2019-nCoV assay realizes increase of throughput using test in one tube and automation system.
Feb 13, 2020｜ Allplex™ 2019-nCoV assay
-
Obtained approval of MFDS for Allplex™ Respiratory Panel3
Allplex™ Respiratory Panel 3 has received approval from Korean Ministry of Food and Drug Safety (MFDS). This assay is a One-step real-time RT-PCR assay to detect simultaneously Bocavirus, Rhinovirus and three Coronaviruses (NL63, 229E, OC43) which cause respiratory infections in a single tube.
Nov 24, 2016｜ Allplex™ Respiratory Panel 3
-
Obtained approval of MFDS for Allplex™ Respiratory Panel1
Allplex™ Respiratory Panel 1 has received approval from Korean Ministry of Food and Drug Safety (MFDS). This assay is a One-step real-time RT-PCR assay to detect simultaneously Flu A, Flu B, RSV A and RSV B with Flu A subtyping in a single tube, which enables appropriate antiviral drug treatments
Sep 01, 2016｜ Allplex™ Respiratory Panel 1
-
Obtained CE-IVD marking for Anyplex™ MERS-CoV Real-time Detection
Anyplex™ MERS-CoV(upE) Real-time Detection, Anyplex™ MERS-CoV (upE&orf1a) Real-time Detection Anyplex™ MERS-CoV (upE) Real-time Detection is a multiplex real-time one-step RT-PCR assay targeting upstream of the E protein gene (upE) for detection of MERS-CoV. The assay for the upE target is considered highly sensitive and is recommended for screening of MERS-CoV. Anyplex™ MERS-CoV (upE&orf1a) Real-time Detection is a multiplex real-time one-step RT-PCR assay targeting upstream of the E protein gene (upE) and orf1a gene for screening and confirmation of MERS-CoV.
Jul 27, 2015｜ Anyplex™ MERS-CoV(upE & orf1a) Real-time Detection
-
Launched Allplex™ Respiratory Full Panel Assay
Multiplex One-step RT Real-time PCR assay for reliable test results Allplex™ Respiratory Full Panel assay that composed of 4 different panels is a multiplex One-step RT Real-time PCR assay to detect and identify 16 viruses, 7 bacteria and 3 Flu A subtypes in patient’s specimens. Based on Seegene’s proprietary MuDT™ technology, this assay makes it possible to report individual Ct value of multiple pathogens in a single channel on real-time PCR instrument.Allplex™ Respiratory Full Panel AssayComprehensive assay for the detection and identification of 26 pathogens using One-step RT Real-time PCR
Mar 23, 2015｜ Allplex™ Respiratory Panel Assays
-
Launched Anyplex™ II RB5 Detection
Anyplex™ II RB5 Detection1Simultaneous detection of 5 Respiratory bacteriaAnyplex™ II RB5 Detection detects 5 respiratory bacteria in a single real-time PCR. Mycoplasma pneumoniae (MP), Chlamydophila pneumoniae (CP), and Legionella pneumophila (LP) are the most common causes of atypical pneumonia. As these atypical pathogens do not respond to β-lactam antimicrobial therapy commonly used for bacterial community-acquired pneumonia (CAP), accurate diagnosis beyond clinical assessment is critical for determination of optimal and effective treatment. Anyplex™ II RB5 Detection has been developed using Seegene's proprietary TOCE™ Technology as a rapid and simple multiplex molecular diagnostic to simultaneously detect and differentiate CAP-related pathogens with high sensitivity and specificity. In addition, Anyplex™ II RB5 also detects and differentiates two causative agents of whooping cough, the commonly detected Bordetella pertussis(BP) as well as the less common but vaccination-ineffective Bordetella parapertussis(BPP). In addition to enabling detection and differentiation of these 5 pathogens, responsible for the respiratory bacteria infections, Anyplex™ II RB5 providing valuable information for more precise diagnosis, effective treatment and clinical follow-up.
Aug 31, 2012｜ Anyplex™Ⅱ RB5 Detection
-
Obtained CE-IVD marking for Anyplex™ II RV16 Detection
Anyplex™ II RV16 DetectionSimultaneous detection of 16 respiratory viruses Seegene's Anyplex™ II RV16 Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.NOT AVAILABLE IN US
Dec 23, 2011｜ Anyplex™Ⅱ RV16 Detection
-
Simultaneous detection of 16 viruses using real-time instrumentation
Anyplex™ RV16 Detection Multiple detection of 16 Respiratory virues using real-time instrumentation
Oct 24, 2011｜ Anyplex™Ⅱ RV16 Detection
